Experimental study on the simultaneous desulfurization and denitrification by duct injection

The highly active absorbent with oxidization based on fly ash, lime and additive was prepared. Experiments of simultaneous desulfurization and denitrification were carried out using fixture bed and duct injection. The influencial factors for the absorptive capacity of the absorbent were studied. The absorptive capacities of 120.7 mg for SO 2 and 43.7 mg for NOx were achieved at a Ca/(S+N) molar ratio 1.2, respectively, corresponding removal efficiencies of 87% and 76%, while spent absorbent appeared in the form of dry powder. The optimal temperature and humidity of flue gas treated with this process were shown to be approximately 50℃, and 5% respectively. The mechanism of removal for SO 2 and NOx was investigated. In comparison with traditional dry FGD, this process appears to have lower cost, less complicated configuration and simpler disposal of used absorbent. The valuable references can be provided for industrial application by this process. The foreground of application will be vast in China and in the world.

Mineralogy of clean coal combustion by-products

Coal combustion technologies are changing in order to burn coal more cleanly.Many 'clean combustion' and post-combustion technologies are developed to remove SO_2 and NO_xgases, particulate matter during combustion, or from the flue gases leaving the furnace. This paperfocuses on three types of fly ash (flue gas desulfurization (FGD) residuals, atmospheric fluidizedbed combustion (AFBC) residuals and sorbent duct injection (SDI) residuals) which produced by 'theclean combustion' and post-combustion technologies. The residuals formed by FGD are PCFA (pulverizedcoal fly ash) grains entrained with reacted and unre-acted sorbent and have lower bulk densitiesthan PCFA grains because it contains higher concentrations of calcium and sulfur, and lowerconcentrations of silicon, aluminum and iron than PCFAs. AFBC residuals consist of spent bed whichis a heterogeneous mixture of coarse-grained bed material and irregularly shaped, unfused, sphericalPCFAs. The main crystalline phases in AFBC residuals are anhydrite (reacted sorbent), quartz andlime (unreacted sobent), calcite, hematite, periclase, magnetite and feldspars. The residualsproduced by SDI contained 65 percent-70 percent PCFA with the larger sizes material beingirregularly shaped, fused or rough-edged. The reaction products of sorbent (portlandite and lime)included calcium sulfate (anhydrite) and calcium sulfate. The chemical properties of these residualsare similar to those of high calcium PCFAs because of the high alkalinity and high pH of theseresiduals.

Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial

AIM: To determine the efficacy of rectally administered naproxen for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).METHODS: This double-blind randomized control trial conducted from January 2013 to April 2014 at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran. A total of 324 patients were selected from candidates for diagnostic or therapeutic ERCP by using the simple sampling method. Patients received a single dose of Naproxen (500 mg; n = 162) or a placebo (n = 162) per rectum immediately before ERCP. The overall incidence of PEP, incidence of mild to severe PEP, serum amylase levels and adverse effects were measured. The primary outcome measure was the development of pancreatitis onset of pain in the upper abdomen and elevation of the serum amylase level to > 3 × the upper normal limit (60-100 IU/L) within 24 h after ERCP. The severity of PEP was classified according to the duration of therapeutic intervention for PEP: mild, 2-3 d; moderate 4-10 d; and severe, > 10 d and/or necessitated surgical or intensive treatment, or contributed to death.RESULTS: PEP occurred in 12% (40/324) of participants, and was significantly more frequent in the placebo group compared to the naproxen group (P < 0.01). Of the participants, 25.9% (84/324) developed hyperamylasemia within 2 h of procedure completion, among whom only 35 cases belonged to the naproxen group (P < 0.01). The incidence of PEP was significantly higher in female sex, in patients receiving pancreatic duct injection, more than 3 times pancreatic duct cannulations, and ERCP duration more than 40 min (Ps < 0.01). There were no statistically significant differences between the groups regarding the procedures or factors that might increase the risk of PEP, sphincterotomy, precut requirement, biliary duct injection and number of pancreatic duct cannulations. In the subgroup of patients with pancreatic duct injection, the rate of pancreatitis in the naproxen group was significantly lower than that in the placebo (6 patients vs 23 patients, P < 0.01, RRR = 12%, AR = 0.3, 95%CI: 0.2-0.6). Naproxen reduced the PEP in patients with ≥ 3 pancreatic cannulations (P < 0.01, RRR = 25%, AR = 0.1, 95%CI: 0.1-0.4) and an ERCP duration > 40 min (P < 0.01, RRR = 20%, AR = 0.9, 95%CI: 0.4-1.2).CONCLUSION: Single dose of suppository naproxen administered immediately before ERCP reduces the incidence of PEP.

Mechanism of adjusting bypass ratio by front variable area bypass injector for a variable cycle engine

The Front Variable Area Bypass Injector(FVABI)is a key to bypass ratio adjustment for a Variable Cycle Engine(VCE).In order to study the role of the FVABI with the Core Driven Fan Stage(CDFS)duct,firstly,the engine bypass with the CDFS duct model and the equivalent engine bypass without the CDFS duct model are designed using the concept of a jet boundary line.By comparing the difference between airflow driving forces in the two engine bypass models,the quantitative effects of the injection from the CDFS duct on the mass flow rate of the engine bypass airflow are obtained under different combinations of pressure difference and area ratios.Then,the CDFS duct injection characteristic map is obtained through the typical experiment of the FVABI.Based on this map,the performance model of the FVABI is developed.Finally,the turbofan engine model with the Variable Inlet Guide Vane(VIGV),the First Variable Cycle Engine model(VCE1)with the CDFS duct and without the VIGV,and the Second Variable Cycle Engine model(VCE2)with the CDFS duct and VIGV are built.The gain on the engine bypass ratio adjustment range caused by the injection from the CDFS duct is clarified by comparing the three engine models.It is concluded that the bypass ratio adjustment range of the variable cycle engine with the FVABI is about twice that of the traditional turbofan engine.